메뉴 건너뛰기




Volumn 61, Issue 10, 2003, Pages 1463-

Agonists versus levodopa in PD: the thrilla of whitha: Reply from the Authors

Author keywords

[No Author keywords available]

Indexed keywords


EID: 85026159031     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (1)

References (13)
  • 1
    • 0037432003 scopus 로고    scopus 로고
    • Agonists vs levodopa in PD: the thrilla of whitha.
    • Wooten GF. Agonists vs levodopa in PD: the thrilla of whitha. Neurology 2003; 60: 360-362.
    • Wooten GF. Agonists vs levodopa in PD: the thrilla of whitha. Neurology 2003; 60: 360-362.
    • (2003) Neurology , vol.60 , pp. 360
    • Wooten, G.F.1
  • 2
    • 0037432067 scopus 로고    scopus 로고
    • Slowing Parkinson’s disease progression: recent dopamine agonist trials.
    • Ahlskog JE. Slowing Parkinson’s disease progression: recent dopamine agonist trials. Neurology 2003; 60: 381-389.
    • Ahlskog JE. Slowing Parkinson’s disease progression: recent dopamine agonist trials. Neurology 2003; 60: 381-389.
    • (2003) Neurology , vol.60 , pp. 381
    • Ahlskog, J.E.1
  • 3
    • 0037432040 scopus 로고    scopus 로고
    • Initial agonist treatments of Parkinson disease: a critique.
    • Albin RL, Frey KA. Initial agonist treatments of Parkinson disease: a critique. Neurology 2003; 60: 390-394.
    • (2003) Neurology , vol.60 , pp. 390
    • Albin, R.L.1    Frey, K.A.2
  • 4
    • 0034684139 scopus 로고    scopus 로고
    • Pramipexole vs. levodopa as initial treatment Parkinson disease: a randomized controlled trial.
    • Parkinson Study Group. Pramipexole vs. levodopa as initial treatment Parkinson disease: a randomized controlled trial. JAMA 2000; 284: 1931-1938.
    • (2000) JAMA , vol.284 , pp. 1931
  • 5
    • 0034682308 scopus 로고    scopus 로고
    • A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa.
    • Rascol O, Brooks D, Korczyn A, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. N Engl J Med 2000; 342: 1484-1491.
    • (2000) N Engl J Med , vol.342 , pp. 1484
    • Rascol, O.1    Brooks, D.2    Korczyn, A.3
  • 6
    • 0031876080 scopus 로고    scopus 로고
    • Factor structure of the Unified Parkinson’s Disease Rating Scale: motor examination.
    • Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson’s Disease Rating Scale: motor examination. Mov Disord 1998; 13: 633-636.
    • (1998) Mov Disord , vol.13 , pp. 633
    • Stebbins, G.T.1    Goetz, C.G.2
  • 7
    • 0031985731 scopus 로고    scopus 로고
    • Early treatment of Parkinson’s disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial.
    • Rinne UK, Bracco F, Chouza C, et al. Early treatment of Parkinson’s disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. Drugs 1998; 55: 23-30.
    • (1998) Drugs , vol.55 , pp. 23
    • Rinne, U.K.1    Bracco, F.2    Chouza, C.3
  • 8
    • 0002449682 scopus 로고    scopus 로고
    • The REAL-PET study: slower progression in early Parkinson’s disease treated with ropinirole compared withl-dopa.
    • Whone AL, Remy P, Davis MR, et al. The REAL-PET study: slower progression in early Parkinson’s disease treated with ropinirole compared with l -dopa. Neurology 2002; 58 (suppl): A82-A83.
    • (2002) Neurology , vol.58
    • Whone, A.L.1    Remy, P.2    Davis, M.R.3
  • 9
    • 0013080285 scopus 로고    scopus 로고
    • Dopa dyskinesias and fluctuations are not related to dopa treatment duration.
    • Muenter MD, Ahlskog JE. Dopa dyskinesias and fluctuations are not related to dopa treatment duration. Ann Neurol 2000; 48: 464.
    • (2000) Ann Neurol , vol.48 , pp. 464
    • Muenter, M.D.1    Ahlskog, J.E.2
  • 10
    • 0035353725 scopus 로고    scopus 로고
    • Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.
    • Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001; 16: 448-458.
    • (2001) Mov Disord , vol.16 , pp. 448
    • Ahlskog, J.E.1    Muenter, M.D.2
  • 11
    • 0035856448 scopus 로고    scopus 로고
    • Ten-year follow-up of three different initial treatments in de-novo PD. A randomized trial.
    • Lees AJ, Katzenschlager R, Head J, et al. Ten-year follow-up of three different initial treatments in de-novo PD. A randomized trial. Neurology 2001; 57: 1687-1684.
    • (2001) Neurology , vol.57 , pp. 1687
    • Lees, A.J.1    Katzenschlager, R.2    Head, J.3
  • 12
    • 85026172471 scopus 로고    scopus 로고
    • Hume D. An enquiry concerning human understanding (Oxford Philosophical Texts). Oxford: Oxford University Press, 1999.
    • Hume D. An enquiry concerning human understanding (Oxford Philosophical Texts). Oxford: Oxford University Press, 1999.
  • 13
    • 85026180264 scopus 로고    scopus 로고
    • Beauchamp TL, Childress JF. Principles of biomedical ethics, 5th ed. Oxford: Oxford University Press, 2001.
    • Beauchamp TL, Childress JF. Principles of biomedical ethics, 5th ed. Oxford: Oxford University Press, 2001.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.